← Open Payments lookup

RAVI GOKLANEY: Open Payments

NPI 1437212636 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$88,734 in 146 payments from 11 companies in 2025. Trend: 2023 $14,542 · 2024 $12,922 · 2025 $88,734

Speaker / faculty: $48,710Consulting: $28,369Travel & lodging: $6,353Food & beverage: $5,302
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)55$40,547
Alkermes, Inc.48$29,935
E.R. Squibb & Sons, L.L.C.14$8,702
Otsuka America Pharmaceutical, Inc.11$8,363
Teva Pharmaceuticals USA, Inc.8$424
Janssen Pharmaceuticals, Inc3$271
Vanda Pharmaceuticals Inc.2$150
Neurocrine BioSciences, Inc.2$137
ABBVIE INC.1$125
Otsuka Pharmaceutical Development & Commercialization, Inc.1$62

Products named: CAPLYTA, LYBALVI, REXULTI, ARISTADA, UZEDY, INVEGA SUSTENNA, COBENFY, FANAPT.

Industry payments across CA — which companies pay providers there.